IRCT2015092824236N1已完成3 期
The effect of Donepezil on cognitive disturbances due to Selective Serotonine reuotake Inhibitor drugs in major Depressive disorders
Vice Chancellor for Research of Shahid Sadoughi University of Medical Sciences0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 40 years（—）
- 性别
- All
入选标准
- •Patients in the age range 30 to 40 years, Complete the consent form, with major Depression according to the text of the revised fourth edition of Diagnostic and Statistical Manual of Mental Disorders, Treated with selective Serotonin reuptake inhibitors, Two months after receiving Antidepressant assessment exam Montreal is less than 26.
- •Exclusion criteria: At the same time suffering from major Depression and other mental disorders. At the same time suffering from major Depression and a physical disorder with features of cognitive impairment including Alzheimer or other degenerative neurological disorders, head injuries or Hypothyroidism. Concomitant use of Anticholinergic agents and nervous system Depressant drugs
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Efficacy of Donepezil in Amnisia due to Electro Convulsive TherapyIRCT2017022532766N1Kurdistan University of Medical Sciences70
已完成
2 期
The effect of donepezil on the persistent cognitive executive function deficit in traumatic brain injury patientspersistent cognitive executive function deficit in traumatic brain injury patients.Intracranial injuryIRCT20130416013027N4Rasht University of Medical Sciences17
已完成
不适用
Influence of donepezil to behavioral and psychological symptoms of frontotemporal dementiaFrontotemporal dementiaJPRN-UMIN000003239ational Hospital Organization Kikuchi Hospital25
已完成
不适用
Evaluating the effect of Donepezil on Cerebral Blood Flow Velocity in Alzheimer's diseaseCondition 1: Alzheimer's disease. Condition 2: Alzheimer's disease.Dementia in Alzheimer's diseaseAlzheimer's diseaseIRCT138812183518N1Isfahan University of Medical Sciences, Isfahan, Iran30
Unknown
4 期
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaImpaired CognitionSchizophreniaNCT01490567Central South University80